GeneDesign opens large-scale production facility in Osaka 23-Apr-2019 By Vassia Barba The Ajinomoto subsidiary opens a development and production base for oligonucleotide drug substances in Japan.
Ajinomoto continues $100m investment to build out worldwide services 26-Mar-2019 By Ben Hargreaves Aji Bio-Pharma will add a flexible fill line, packaging and labelling equipment to its worldwide manufacturing network, in an investment worth upwards of $100m.
